Welcome to Advanced Search

Models

About 63 results
Cells

NCI-H1975 [H-1975, H1975]

Strain Name:NCI-H1975 [H-1975, H1975]
Strain State : Validation of tumorigenic capacity completed |  Cat. NO.:NM-F07

NCI-H1975 (H-1975, H1975) is a cell line exhibiting epithelial morphology that was isolated in 1988 from the lungs of a nonsmoking female with non-small cell lung cancer.

Literature
Literature
Literature
Literature

Thalidomide targets EGFL6 to inhibit EGFL6/PAX6 axis-driven angiogenesis in small bowel vascular malformation

Model Organisms:Zebrafish Product & Service:EGFL6,pax6a Research field:Angiogenesis

Literature
Literature

E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer

Model Organisms:小鼠 Product & Service:Mkrn3-Flox Research field:Cancer Research

Literature
Literature

Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical...

Model Organisms:小鼠 Product & Service:M-NSG Research field:Non-Small Cell Lung Carcinoma

Pages

Webinar on Advances in Antibody-Drug Conjugates (ADCs) Development & Preclinical Models

Antibody-Drug Conjugates ADC Development Preclinical Models Targeted Cancer Therapies GenoBioTX ADC Webinar Biopharma Research Oncology Biochemistry Cancer Treatment Preclinical Evaluation Monoclonal Antibodies Small Molecule Drugs

Join us for a webinar on June 26th, 2024, exploring the development and preclinical evaluation of Antibody-Drug Conjugates (ADCs). Learn from Dr. Hua Wei, VP of the Industrial Clients Department at GenoBioTX, about ADC components, mechanisms, historical evolution, and future directions.

Email Back to top